Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
Lineage Cell Therapeutics, Inc. (BTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/27/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 04/28/2020 |
10-K/A
| Annual Report for the period ended December 31, 2019 [amend] |
| 05/01/2019 |
10-K/A
| Annual Report for the period ended December 31, 2018 [amend] |
| 04/30/2019 |
10-K/A
| Annual Report for the period ended December 31, 2018 [amend] |
| 04/02/2018 |
10-K/A
| Annual Report for the period ended December 31, 2017 [amend] |
| 03/28/2017 |
10-K/A
| Annual Report for the period ended December 31, 2016 [amend] |
| 05/24/2016 |
10-K/A
| Annual Report for the period ended December 31, 2015 [amend] |
| 04/29/2015 |
10-K/A
| Annual Report for the period ended December 31, 2014 [amend] |
| 04/29/2014 |
10-K/A
| Annual Report for the period ended December 31, 2013 [amend] |
| 04/30/2013 |
10-K/A
| Annual Report for the period ended December 31, 2012 [amend] |
| 09/17/2012 |
10-K/A
| Annual Report for the period ended December 31, 2011 [amend] |
| 07/05/2011 |
10-K/A
| Annual Report for the period ended December 31, 2010 [amend] |
| 03/16/2011 |
10-K/A
| Annual Report for the period ended December 31, 2010 [amend] |
| 04/14/2003 |
10-K/A
| Annual Report for the period ended December 31, 2002 [amend] |
| 05/15/2002 |
10-K/A
| Annual Report for the period ended December 31, 2001 [amend] |
|
|